MetaBiom
Microbiome & Chronic Diseases

Evidence Based Medicine
Sign in
≡ List 

Disease ⇒ Psoriasis {40000128}

Record Keys


Type:
Disease
Definition:
Psoriasis
Parent:[  ]

Details


Initialisation date:
2020-09-06
Other Terms:[  ]

Links


Meta Information


MedDra ID:
10037153
MedDra Level:
pt
ICD:[  ]
Category:
Dermatology
Zone:[  ]
Mechanism:[  ]

Notes:


- Among bacterial species with higher abundance in the psoriasis gut microbiome, Bacteroides vulgatus and Parasutterella excrementihominis have been associated with other immune-mediated diseases.
- Increased intestinal colonization of Bacteroides vulgatus and elevated Bacteroides vulgatus reactive serum antibodies have been reported in ulcerative colitis patients.
- Moreover, colonization of Bacteroides vulgatus is sufficient to promote colitis in several animal models, which further supports the active role of Bacteroides vulgatus in development of colitis.
- The abundance of Akkermansia muciniphila was significantly reduced in patients with psoriasis .
- A. muciniphila is believed to have an important function in the pathogenesis of IBD and obesity; therefore, A. muciniphila, which is an indicator of health status, may be a key node for psoriasis as well as IBD and obesity. (1)

References Notes


[  ]

Shared Reference Notes


  • [1.21
    - Altered gut barrier in psoriasis is associated with gastrointestinal symptoms, systemic inflammatory profile and the increased blood concentration of gut microbiota-derived metabolite – TMAO.
  • [1.22
    - Biologic therapy may have an impact on the composition of the gut microbiome of psoriatic patients.
  • [1.23
    - Orally administered EDP1867, a gamma-irradiated strain of Veillonella parvula, rapidly transits through the murine gut without colonization or alteration of the background microbiome flora.
    - In murine models of inflammatory disease including delayed-type hypersensitivity (DTH), atopic dermatitis, psoriasis, and experimental autoimmune encephalomyelitis (EAE), treatment with EDP1867 resulted in significant reduction in inflammation and immunopathology.
  • [1.19
    - abundance of A. muciniphila was significantly decreased in patients with psoriasis.
    - In patients with moderate-to-severe psoriasis, serum markers of intestinal barrier integrity injury increased.
    - intestinal fatty acid binding protein, a biomarker of intestinal barrier damage, significantly elevated in patients with psoriasis.
  • [1.27
    - The psoriatic subject showed a decrease in Firmicutes abundance and an increase in Proteobacteria abundance.
    - An increase in Streptococcaceae, Rhodobacteraceae, Campylobacteraceae and Moraxellaceae has been observed in psoriatic subject.

Common References